Legal & General Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-40,170
| Closed | -$632K | – | 3557 |
|
|
2024
Q1 | $632K | Hold |
40,170
| – | – | ﹤0.01% | 2343 |
|
|
2023
Q4 | $648K | Sell |
40,170
-4,909
| -11% | -$62.6K | ﹤0.01% | 2359 |
|
|
2023
Q3 | $573K | Sell |
45,079
-456
| -1% | -$6.29K | ﹤0.01% | 2380 |
|
|
2023
Q2 | $641K | Buy |
45,535
+20,620
| +83% | +$295K | ﹤0.01% | 2374 |
|
|
2023
Q1 | $385K | Buy |
24,915
+6,024
| +32% | +$101K | ﹤0.01% | 2389 |
|
|
2022
Q4 | $310K | Buy |
18,891
+754
| +4% | +$12.3K | ﹤0.01% | 2457 |
|
|
2022
Q3 | $336K | Sell |
18,137
-6,745
| -27% | -$106K | ﹤0.01% | 2449 |
|
|
2022
Q2 | $327K | Buy |
24,882
+8,487
| +52% | +$93.7K | ﹤0.01% | 2461 |
|
|
2022
Q1 | $152K | Sell |
16,395
-17,328
| -51% | -$147K | ﹤0.01% | 2763 |
|
|
2021
Q4 | $330K | Buy |
33,723
+3,267
| +11% | +$61.4K | ﹤0.01% | 2541 |
|
|
2021
Q3 | $1.03M | Buy |
30,456
+7,919
| +35% | +$253K | ﹤0.01% | 2242 |
|
|
2021
Q2 | $825K | Buy |
22,537
+227
| +1% | +$8.79K | ﹤0.01% | 2243 |
|
|
2021
Q1 | $1M | Sell |
22,310
-50
| -0.2% | -$2.33K | ﹤0.01% | 2194 |
|
|
2020
Q4 | $1.28M | Sell |
22,360
-37
| -0.2% | -$2.19K | ﹤0.01% | 2044 |
|
|
2020
Q3 | $1.15M | Sell |
22,397
-1,645
| -7% | -$80.6K | ﹤0.01% | 1980 |
|
|
2020
Q2 | $1.44M | Buy |
24,042
+12,094
| +101% | +$647K | ﹤0.01% | 1866 |
|
|
2020
Q1 | $492K | Sell |
11,948
-26,372
| -69% | -$1.46M | ﹤0.01% | 2071 |
|
|
2019
Q4 | $2.38M | Buy |
38,320
+33,766
| +741% | +$1.6M | ﹤0.01% | 1713 |
|
|
2019
Q3 | $155K | Buy |
4,554
+1,770
| +64% | +$52.4K | ﹤0.01% | 2410 |
|
|
2019
Q2 | $62K | Buy |
2,784
+1,137
| +69% | +$26.6K | ﹤0.01% | 2688 |
|
|
2019
Q1 | $39K | Hold |
1,647
| – | – | ﹤0.01% | 2808 |
|
|
2018
Q4 | $35K | Hold |
1,647
| – | – | ﹤0.01% | 2835 |
|
|
2018
Q3 | $64K | Buy |
1,647
+587
| +55% | +$21.7K | ﹤0.01% | 2659 |
|
|
2018
Q2 | $42K | Sell |
1,060
-372
| -26% | -$10.9K | ﹤0.01% | 2836 |
|
|
2018
Q1 | $29K | Hold |
1,432
| – | – | ﹤0.01% | 2996 |
|
|
2017
Q4 | $33K | Buy |
+1,432
| New | +$28K | ﹤0.01% | 3020 |
|
Other funds holding DCPH
Legal & General Group's DCPH Position: Q2 2024 in Review
Legal & General Group sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 40,170 shares — an estimated $632K sold.
Legal & General Group first reported a position in DCPH in Q4 2017 and held it in 26 quarters. The position peaked at $2.38M in Q4 2019. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Legal & General Group reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Legal & General Group sold 40,170 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $632K.
- Legal & General Group first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 26 quarters.
- Legal & General Group's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $2.38M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Legal & General Group's 13F filing for Q2 2024, filed 14 Aug 2024.